We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Echocardiography Service Automatically Identifies Coronary Artery Disease

By HospiMedica International staff writers
Posted on 21 Jan 2021
An artificial intelligence (AI) powered, outcomes-driven, decision support tool improves the diagnostic accuracy of clinicians for coronary artery disease (CAD).

The Ultromics (Oxford, United Kingdom) EchoGo Pro is a fully automated solution for echocardiography and strain analysis. More...
The cloud-based Software-as-a-Service (SaaS) platform uses AI to power the diagnostic pathway, providing near-instant reports without any need for physical software on site. EchoGo Pro complements EchoGo Core, a software application that measures standard cardiac parameters, including ejection fraction (EF), global longitudinal dtrain (GLS), and left ventricular (LV) volume, and also analyzes echocardiogram (ECG) cardiac parameters.

For Pro, the anonymized echocardiogram dataset is transferred and processed through the application’s workflow, and an auto-contouring algorithm places points around the LV that sufficiently capture the LV shape; these contours are then used for calculating geometric parameters. By automating ECG analysis as part of the cloud service, a complete accurate analysis can be delivered within minutes, and with zero variability, in a zero-click workflow, aiding identification of CAD. EchoGo Pro and EchoGo Core will be offered together in the EchoGo suite.

“Heart disease is the biggest killer globally, and this number is increasing daily. COVID-19 has placed an even greater pressure on cardiac care and looks likely to have lasting implications in terms of its impact on the heart,” said Ross Upton, MD, founder and CEO of Ultromics. “The healthcare industry needs to quickly pivot towards AI powered automation to reduce the time to diagnosis and improve patient care. We are making the EchoGo suite as complete and automated as possible to help clinicians rapidly assess disease and provide early, appropriate intervention.”

Cardiac ultrasound, or echocardiography, is a noninvasive diagnostic modality that can provide detailed hemodynamic information rapidly at the patient bedside. It was first adopted for diagnostic purposes in the 1960s as an inexpensive way to expedite diagnosis and management of imminently life-threatening cardiac disease, including pericardial tamponade, acute coronary syndrome (ACS), cardiomyopathy, pulmonary embolism (PE), and aortic dissection. Cardiac ultrasound can also differentiate shock states and guide resuscitative measures.

Related Links:
Ultromics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Vessel Sealing Instrument
ERGOseal
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.